ALFA Filings
Every announcement, straight from the exchange
Every Sun Pharmaceutical Industries other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Sun Pharmaceutical Industries submitted the quarterly confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, as received from their RTA.
Sun Pharma established an endowed professorship at Icahn School of Medicine at Mount Sinai with a $2.5 million grant to advance dermatology research and education.
Sun Pharmaceutical informed the exchanges that its board meeting concluded on July 31, 2026, after adjourning for a break during the session.
Sun Pharma's independent director Mr. Gautam Doshi has been arrested in an unrelated matter. The company sees no impact on its operations or board.
Sun Pharma will present long-term follow-up data for UNLOXCYT at the ASCO 2026 meeting. The study shows durable responses and a manageable safety profile for laCSCC patients.
Sun Pharmaceutical Industries Ltd submitted its quarterly confirmation certificate for the period ended March 31, 2026, regarding the dematerialisation of securities. The registrar, MUFG Intime India, confirmed compliance with SEBI (Depositories and Participants) Regulations. This is a routine administrative filing with no material impact on business operations.